| Literature DB >> 31390813 |
Hong-Yi Ji1,2, Christian Staehelin3, Yan-Ping Jiang1,4, Shi-Wei Liu1,2, Zhi-Hui Ma1,2, Yi-Juan Su1,2, Jia-En Zhang5,6, Rui-Long Wang7,8.
Abstract
Nicotinamide adenine dinucleotide phosphate (NADPH)-cytochrome P450 reductases (CPRs) function as redox partners of cytochrome P450 monooxygenases (P450s). CPRs and P450s in insects have been found to participate in insecticide resistance. However, the CPR of the moth Spodoptera litura has not been well characterized yet. Based on previously obtained transcriptome information, a full-length CPR cDNA of S. litura (SlCPR) was PCR-cloned. The deduced amino acid sequence contains domains and residues predicted to be essential for CPR function. Phylogenetic analysis with insect CPR amino acid sequences showed that SlCPR is closely related to CPRs of Lepidoptera. Quantitative reverse transcriptase PCR (RT-qPCR) was used to determine expression levels of SlCPR in different developmental stages and tissues of S. litura. SlCPR expression was strongest at the sixth-instar larvae stage and fifth-instar larvae showed highest expression in the midgut. Expression of SlCPR in the midgut and fat body was strongly upregulated when fifth-instar larvae were exposed to phoxim at LC15 (4 μg/mL) and LC50 (20 μg/mL) doses. RNA interference (RNAi) mediated silencing of SlCPR increased larval mortality by 34.6% (LC15 dose) and 53.5% (LC50 dose). Our results provide key information on the SlCPR gene and indicate that SlCPR expression levels in S. litura larvae influence their susceptibility to phoxim and possibly other insecticides.Entities:
Keywords: NADPH-cytochrome; P450 reductase; RNAi; Spodoptera litura; insecticide susceptibility; phoxim
Mesh:
Substances:
Year: 2019 PMID: 31390813 PMCID: PMC6696589 DOI: 10.3390/ijms20153839
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Sequence analysis of the SlCPR protein (A). The protein contains predicted flavin mononucleotide (FMN)-, flavin adenine dinucleotide (FAD)-, and NADP-binding domains. The proteins also conserved residues such as the FAD-binding motif (R467, Y469, and S470) and the predicted catalytic residues (S470, C641, D686, and W688). (B) Comparison of the deduced amino acid sequence of SlCPR with other NADPH-cytochrome P450 reductases (CPRs). Accession numbers of indicated CPR amino acid sequences are shown in Table 1.
Figure 2Phylogenic analysis of SlCPR and related insect CPRs. Multiple sequence alignment of full-length amino acid sequences of 29 CPR proteins was performed with DNAMAN 6.0 software. The phylogenetic tree was constructed using MEGA7.0 with the neighbor-joining (NJ) method and 1000 bootstrap replicates. Numbers shown at the tree forks indicate frequency of occurrence among all bootstrap iterations performed. The scale bar indicates 0.05 amino acid substitutions per site. CPRs from human and mouse were used as an outgroup. SlCPR is marked by a black solid circle. Accession numbers of indicated CPR amino acid sequences are shown in Table 1.
Percent amino acid identities between SlCPR and other CPRs.
| Order | Species | Accession Number | Identity (%) |
|---|---|---|---|
| Hymenoptera | XP_012541364 | 62.8 | |
| XP_011157063 | 62.6 | ||
| XP_011643152 | 61.5 | ||
| XP_001119949 | 62.1 | ||
| NP_001351669 | 62.6 | ||
| XP_012275162 | 62.6 | ||
| XP_011306347 | 63.4 | ||
| XP_008548684 | 62.3 | ||
| Hemiptera | AGT15701 | 61.9 | |
| AFD50507 | 62.7 | ||
| AID55422 | 63.8 | ||
| AHM93009 | 64.4 | ||
| Coleoptera | AFI45002 | 64.9 | |
| XP_971174 | 67.6 | ||
| Diptera | AAB48964 | 62.8 | |
| NP_477158 | 66.6 | ||
| AAA29295 | 68.4 | ||
| AAO24765 | 66.6 | ||
| EF152578 | 67.5 | ||
| Lepidoptera | NP_001292469 | 79.4 | |
| AGM20565 | 85.4 | ||
| ABJ97709 | 87.0 | ||
| NP_001104834 | 87.0 | ||
| ADK25060 | 95.6 | ||
| ADX95746 | 98.4 | ||
| AFP20584 | 99.6 | ||
| MH638288 | 100 | ||
| Rodentia | NM_008898 | 53.5 | |
| Primates | NP_000932 | 56.2 |
Figure 3Relative expression levels of SlCPR at different development stages (A) and in various tissues (B). Whole body of S. litura larvae were used for the different development stages, while fifth-instar larvae were used for various tissues. Expression levels of SlCPR were determined by quantitative reverse transcriptase PCR (RT-qPCR), and β-actin and EF1 were selected as reference genes. Each RT-qPCR reaction for each sample was performed in three biological replicates and three technical replicates. Data shown are means ± SE. Different letters (a,b,c,d) above bars indicate significant differences (p < 0.05) according to Duncan’s multiple range test. Abbreviations: 1st to 6th—first- to sixth-instar larvae; C—cuticle; FB—fat body; MG—midgut; H—head; MT—Malpighian tubule; HC—hemocytes.
Figure 4Effects of phoxim on SlCPR expression in the midgut and fat body of fifth-instar larvae. Larvae were exposed to phoxim at LC15 (4 μg/mL) and LC50 (20 μg/mL) doses for 24 h. SlCPR expression levels were normalized to β-actin and EF1 expression and presented as the means ± SE with three independent biological replicates and three technical replicates. Different letters (a,b,c) above bars indicate significant differences (p < 0.05) according to Duncan’s multiple range test.
Figure 5RNA interference (RNAi)-mediated silencing of SlCPR in fifth-instar larvae. Larvae were microinjected with dsCPR or dsGFP (control). RNA was isolated at indicated time points after microinjection. Expression levels of SlCPR in the midgut (A) and fat body (B) were then determined by RT-qPCR. The expression levels of SlCPR were normalized using β-actin and EF1 as reference genes. Each RT-qPCR reaction for each sample was performed in three technical replicates and three biological replicates. Data indicate means ± SE. Asterisks indicate significantly reduced expression levels in SlCPR-silenced larvae as compared to the control group (Student’s t-test, * p < 0.05,** p < 0.01, *** p < 0.001).
Figure 6Effect of SlCPR silencing on the susceptibility to phoxim. Fourth-instar larvae were microinjected with dsCPR or dsGFP (control). Thirty fifth-instar larvae were then exposed to phoxim at LC15 (4 μg/mL) or LC50 (20 μg/mL) doses for 48 h. All tests were performed in triplicate. Data shown are mortality rates (means ± SE). Asterisks indicate significant differences between SlCPR-silenced larvae as compared to the control group (Student’s t-test, ** p < 0.01, *** p < 0.001).